Results 141 to 150 of about 17,271 (194)

Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity. [PDF]

open access: yesProstate
Quarta L   +17 more
europepmc   +1 more source

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer. [PDF]

open access: yesInvest New Drugs
Chandran K   +26 more
europepmc   +1 more source

Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer. [PDF]

open access: yesJ Natl Cancer Inst
Lu-Yao G   +11 more
europepmc   +1 more source

Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis. [PDF]

open access: yesTarget Oncol
Di Civita MA   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy